We are humans revolutionizing the future of healthcare diagnostics through artificial intelligence
VisionQuest Biomedical was founded in 2007 with the goal of developing and commercializing advanced technologies aimed at improving care in diabetes.
Through grant funding from the National Institutes of Health and private investment this stated strategic objective is being met, as evidenced in the commercialization of two NIH-funded technologies at clinics screening for diabetic retinopathy.
VisionQuest has developed and successfully deployed a software product for automatic analysis of retinal images in the detection of lesions in patients with diabetic retinopathy, age-related macular degeneration (AMD), and glaucoma.
Our automatic, real-time image quality screening system is also now being used in two commercial retinal cameras to ensure the highest possible retinal image quality, critically important for reading centers to make the best possible determination of a case.
VisionQuest Biomedical Milestones
2016
EyeStar deployed in Mexico
2017
Diabetic Foot testing device development.
2018
Aspire clinical testing in Africa
2020
+25,000 patients tested with Eyestar
2021
Bring Eyestar to USA
2022-2025
VisionQuest's products saving visions and lives Worldwide
Our mission is to develop and deploy image-based technologies to improve access to health care for millions of individuals in the United States and around the world, especially in the fields of diabetes and eye care.
Leadership
CTO & Founder
Peter SolizPhD
Pete is the principal investigator on the NIH grants that funded the development of EyeStar. He continues his mission of developing AI technologies for health care and securing additional non-dilutive funding.
Our Team
Contact Us
Send us a message, we want to hear from you.